Cargando…

Human cardiac tissue in a microperfusion chamber simulating extracorporeal circulation - ischemia and apoptosis studies

BACKGROUND: After coronary artery bypass grafting ischemia/reperfusion injury inducing cardiomyocyte apoptosis may occur. This surgery-related inflammatory reaction appears to be of extreme complexity with regard to its molecular, cellular and tissue mechanisms and many studies have been performed o...

Descripción completa

Detalles Bibliográficos
Autores principales: Usta, Engin, Renovanz, Mirijam, Mustafi, Migdat, Ziemer, Gerhard, Aebert, Hermann
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821307/
https://www.ncbi.nlm.nih.gov/pubmed/20082695
http://dx.doi.org/10.1186/1749-8090-5-3
_version_ 1782177422236450816
author Usta, Engin
Renovanz, Mirijam
Mustafi, Migdat
Ziemer, Gerhard
Aebert, Hermann
author_facet Usta, Engin
Renovanz, Mirijam
Mustafi, Migdat
Ziemer, Gerhard
Aebert, Hermann
author_sort Usta, Engin
collection PubMed
description BACKGROUND: After coronary artery bypass grafting ischemia/reperfusion injury inducing cardiomyocyte apoptosis may occur. This surgery-related inflammatory reaction appears to be of extreme complexity with regard to its molecular, cellular and tissue mechanisms and many studies have been performed on animal models. However, finding retrieved from animal studies were only partially confirmed in humans. To investigate this phenomenon and to evaluate possible therapies in vitro, adequate human cardiomyocyte models are required. We established a tissue model of human cardiomyocytes preserving the complex tissue environment. To our knowledge human cardiac tissue has not been investigated in an experimental setup mimicking extracorporeal circulation just in accordance to clinical routine, yet. METHODS: Cardiac biopsies were retrieved from the right auricle of patients undergoing elective coronary artery bypass grafting before cardiopulmonary bypass. The extracorporeal circulation was simulated by submitting the biopsies to varied conditions simulating cardioplegia (cp) and reperfusion (rep) in a microperfusion chamber. Cp/rep time sets were 20/7, 40/13 and 60/20 min. For analyses of the calcium homoeostasis the fluorescent calcium ion indicator FURA-2 and for apoptosis detection PARP-1 cleavage immunostaining were employed. Further the anti-apoptotic effect of carvedilol [10 μM] was investigated by adding into the perfusate. RESULTS: Viable cardiomyocytes presented an intact calcium homoeostasis under physiologic conditions. Following cardioplegia and reperfusion a time-dependent elevation of cytosolic calcium as a sign of disarrangement of the calcium homoeostasis occurred. PARP-1 cleavage also showed a time-dependence whereas reperfusion had the highest impact on apoptosis. Cardioplegia and carvedilol could reduce apoptosis significantly, lowering it between 60-70% (p < 0.05). CONCLUSIONS: Our human cardiac preparation served as a reliable cellular model tool to study apoptosis in vitro. Decisively cardiac tissue from the right auricle can be easily obtained at nearly every cardiac operation avoiding biopsying of the myocardium or even experiments on animals. The apoptotic damage induced by the ischemia/reperfusion stimulus could be significantly reduced by the cold crystalloid cardioplegia. The additional treatment of cardiomyocytes with a non-selective β-blocker, carvedilol had even a significantly higher reduction of apoptotis.
format Text
id pubmed-2821307
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28213072010-02-15 Human cardiac tissue in a microperfusion chamber simulating extracorporeal circulation - ischemia and apoptosis studies Usta, Engin Renovanz, Mirijam Mustafi, Migdat Ziemer, Gerhard Aebert, Hermann J Cardiothorac Surg Research article BACKGROUND: After coronary artery bypass grafting ischemia/reperfusion injury inducing cardiomyocyte apoptosis may occur. This surgery-related inflammatory reaction appears to be of extreme complexity with regard to its molecular, cellular and tissue mechanisms and many studies have been performed on animal models. However, finding retrieved from animal studies were only partially confirmed in humans. To investigate this phenomenon and to evaluate possible therapies in vitro, adequate human cardiomyocyte models are required. We established a tissue model of human cardiomyocytes preserving the complex tissue environment. To our knowledge human cardiac tissue has not been investigated in an experimental setup mimicking extracorporeal circulation just in accordance to clinical routine, yet. METHODS: Cardiac biopsies were retrieved from the right auricle of patients undergoing elective coronary artery bypass grafting before cardiopulmonary bypass. The extracorporeal circulation was simulated by submitting the biopsies to varied conditions simulating cardioplegia (cp) and reperfusion (rep) in a microperfusion chamber. Cp/rep time sets were 20/7, 40/13 and 60/20 min. For analyses of the calcium homoeostasis the fluorescent calcium ion indicator FURA-2 and for apoptosis detection PARP-1 cleavage immunostaining were employed. Further the anti-apoptotic effect of carvedilol [10 μM] was investigated by adding into the perfusate. RESULTS: Viable cardiomyocytes presented an intact calcium homoeostasis under physiologic conditions. Following cardioplegia and reperfusion a time-dependent elevation of cytosolic calcium as a sign of disarrangement of the calcium homoeostasis occurred. PARP-1 cleavage also showed a time-dependence whereas reperfusion had the highest impact on apoptosis. Cardioplegia and carvedilol could reduce apoptosis significantly, lowering it between 60-70% (p < 0.05). CONCLUSIONS: Our human cardiac preparation served as a reliable cellular model tool to study apoptosis in vitro. Decisively cardiac tissue from the right auricle can be easily obtained at nearly every cardiac operation avoiding biopsying of the myocardium or even experiments on animals. The apoptotic damage induced by the ischemia/reperfusion stimulus could be significantly reduced by the cold crystalloid cardioplegia. The additional treatment of cardiomyocytes with a non-selective β-blocker, carvedilol had even a significantly higher reduction of apoptotis. BioMed Central 2010-01-18 /pmc/articles/PMC2821307/ /pubmed/20082695 http://dx.doi.org/10.1186/1749-8090-5-3 Text en Copyright ©2010 Usta et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research article
Usta, Engin
Renovanz, Mirijam
Mustafi, Migdat
Ziemer, Gerhard
Aebert, Hermann
Human cardiac tissue in a microperfusion chamber simulating extracorporeal circulation - ischemia and apoptosis studies
title Human cardiac tissue in a microperfusion chamber simulating extracorporeal circulation - ischemia and apoptosis studies
title_full Human cardiac tissue in a microperfusion chamber simulating extracorporeal circulation - ischemia and apoptosis studies
title_fullStr Human cardiac tissue in a microperfusion chamber simulating extracorporeal circulation - ischemia and apoptosis studies
title_full_unstemmed Human cardiac tissue in a microperfusion chamber simulating extracorporeal circulation - ischemia and apoptosis studies
title_short Human cardiac tissue in a microperfusion chamber simulating extracorporeal circulation - ischemia and apoptosis studies
title_sort human cardiac tissue in a microperfusion chamber simulating extracorporeal circulation - ischemia and apoptosis studies
topic Research article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821307/
https://www.ncbi.nlm.nih.gov/pubmed/20082695
http://dx.doi.org/10.1186/1749-8090-5-3
work_keys_str_mv AT ustaengin humancardiactissueinamicroperfusionchambersimulatingextracorporealcirculationischemiaandapoptosisstudies
AT renovanzmirijam humancardiactissueinamicroperfusionchambersimulatingextracorporealcirculationischemiaandapoptosisstudies
AT mustafimigdat humancardiactissueinamicroperfusionchambersimulatingextracorporealcirculationischemiaandapoptosisstudies
AT ziemergerhard humancardiactissueinamicroperfusionchambersimulatingextracorporealcirculationischemiaandapoptosisstudies
AT aeberthermann humancardiactissueinamicroperfusionchambersimulatingextracorporealcirculationischemiaandapoptosisstudies